GlaxoSmithKline said on Tuesday it had agreed to settle certain U.S. lawsuits alleging its Paxil antidepressant caused birth defects in some patients but declined to put a figure on the settlements.
Read the original post:
Glaxo says settles some Paxil birth-defect cases
